List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 59 studies with search of: "Mesalamine"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Once Daily (OD) Versus Three Times Daily (TID) Dosing With Mesalazine Granules for Prevention of Recurrence of Ulcerative Colitis (UC)
Conditions: Colitis, Ulcerative;   Recurrence
Interventions: Drug: mesalamine granules;   Drug: mesalamine granules;   Drug: mesalamine granules
2 Completed Pharmacokinetics of Asacol 2.4 g/Day and Lialda 2.4 g/Day in Healthy Volunteers
Condition: Healthy
Interventions: Drug: Asacol;   Drug: Asacol;   Drug: Lialda
3 Completed A Study of Asacol Absorption, Metabolism and Excretion in Children and Adolescents With Ulcerative Colitis.
Condition: Ulcerative Colitis
Interventions: Drug: mesalamine;   Drug: mesalamine;   Drug: mesalamine
4 Recruiting Canadian Active & Maintenance Modified Pentasa Study
Conditions: Active Ulcerative Colitis;   Remission of Ulcerative Colitis
Interventions: Drug: 5-ASA (5-Aminosalicylate);   Drug: 5-ASA (5-Aminosalicylate)
5 Completed Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day (ASCEND I)
Condition: Ulcerative Colitis
Interventions: Drug: mesalamine;   Drug: mesalamine
6 Completed Efficacy and Safety of Two Doses of SPD476 (Mesalazine) 2.4g and 4.8g Once Daily, With Reference to Asacol 0.8g Three Times Daily in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: SPD476 is a polymeric matrix formulation that displays both delayed- and extended-release of mesalazine;   Drug: Mesalazine
7 Recruiting Asacol Acute Diverticulitis(DIVA)Study
Condition: Diverticulitis
Interventions: Drug: mesalamine;   Other: placebo;   Drug: Mesalamine and Align
8 Completed Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: Asacol (mesalamine);   Drug: asacol 400 mg (mesalamine)
9 Recruiting The Colitis Once Daily Asacol Study
Condition: Ulcerative Colitis
Intervention: Drug: mesalazine (Asacol®)
10 Completed Asacol Dosing Study for Active Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Asacol (mesalamine)
11 Completed Mesalamine Pellet Formulation to Maintain Remission of Mild to Moderate Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: Granulated mesalamine;   Drug: Placebo
12 Recruiting Prevention of Recurrence of Diverticulitis
Condition: Diverticulitis
Interventions: Drug: SPD476, MMX™ mesalazine, 1.2g extended release tablet;   Drug: SPD476, MMX™ mesalazine, 1.2g extended release tablet;   Drug: SPD476, MMX™ mesalazine, 1.2g extended release tablet;   Drug: Placebo
13 Terminated Once Daily Versus Conventional Dosing of Asacol in the Maintenance of Quiescent Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Asacol (mesalamine)
14 Active, not recruiting Budesonide Capsules Versus Mesalazine Granules in Active Ulcerative Colitis (UC)
Condition: Colitis, Ulcerative
Interventions: Drug: budesonide;   Drug: mesalazine
15 Recruiting Mechanistic Randomized Controlled Trial (RCT) of Mesalazine in Symptomatic Diverticular Disease
Condition: Diverticulosis, Colonic
Interventions: Device: Mesalazine;   Drug: Placebo
16 Recruiting The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active "Drug: Crohn's Disease"
Condition: Crohn's Disease
Intervention: Drug: Mesalazine (Mesalamine)
17 Completed Mesalamine 4 gm/60 mL Rectal Enema
Condition: Healthy
Interventions: Drug: Rowasa® 4 gm/60 mL Rectal Enema;   Drug: Mesalamine 4 gm/60 mL Rectal Enema
18 Recruiting Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents With Active Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: Asacol 400 mg;   Drug: Asacol 400 mg
19 Completed Bioavailability Study of Two Mesalamine 4 gm/60 ml Rectal Enema Formulations
Condition: Bioavailability
Intervention: Drug: Mesalamine
20 Recruiting Mesalazine 4g Once Daily Versus 4g in Two Divided Doses in Active Ulcerative Colitis.
Condition: Ulcerative Colitis
Interventions: Drug: Mesalazine;   Drug: Mesalazine

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services